Federal award
ROCHE DIAGNOSTICS CORPORATION
W91YTZ21P0129
Contract
Obligated and Ceiling
- Obligated (net)
- $930,136.95
- Ceiling (potential value, not spending)
- $930,136.95
- Current value
- $930,136.95
- Gross positive obligations
- $1,643,314.50
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ21P0129
- Award type code
- B
- Actions
- 15 · Jul 14, 2021 to May 27, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History15
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 27, 2026 | FY2026 | P00014 | M | $0.00 | — |
| Dec 29, 2025 | FY2026 | P00013 | C | $246,402.82 | — |
| Jun 2, 2025 | FY2025 | P00012 | C | −$50,000.00 | — |
| Apr 9, 2025 | FY2025 | P00011 | C | −$37,103.22 | — |
| Aug 8, 2024 | FY2024 | P00010 | C | $246,402.82 | — |
| Aug 7, 2024 | FY2024 | P00009 | C | −$322,971.86 | — |
| Mar 6, 2024 | FY2024 | P00008 | G | $0.00 | — |
| Sep 14, 2023 | FY2023 | P00007 | C | −$93,817.43 | — |
| Aug 14, 2023 | FY2023 | P00006 | C | $111,300.40 | — |
| Jun 7, 2023 | FY2023 | P00005 | M | −$0.01 | — |
| May 12, 2023 | FY2023 | P00004 | G | $346,402.82 | — |
| May 5, 2023 | FY2023 | P00003 | M | $0.00 | — |
| Jun 2, 2022 | FY2022 | P00002 | G | $346,402.82 | — |
| May 25, 2022 | FY2022 | P00001 | C | −$209,285.03 | — |
| Jul 14, 2021 | FY2021 | 0 | — | $346,402.82 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.